Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for Windows
(clotrimazole oral )
406 results
  • Cutaneous candidiasis - an evidence-based review of topical and systemic treatments to inform clinical practice. [Review]
    J Eur Acad Dermatol Venereol 2019; 33(10):1863-1873Taudorf EH, Jemec GBE, … Saunte DML
  • Cutaneous candidiasis is a common skin disease, and several treatments have been investigated within the last fifty years. Yet, systematic reviews are lacking, and evidence-based topical and systemic treatment strategies remain unclear. Thus, the aim of this review was to summarize efficacy and adverse effects of topical and oral therapies for cutaneous candidiasis in all age groups. Two individu…
  • Therapeutic tools for oral candidiasis: Current and new antifungal drugs. [Review]
    Med Oral Patol Oral Cir Bucal 2019; 24(2):e172-e180Quindós G, Gil-Alonso S, … Eraso E
  • CONCLUSIONS: Nystatin, miconazole, and fluconazole are very effective for treating oral candidiasis. There are systemic alternatives for treating recalcitrant infections, such as the new triazoles, echinocandins, or lipidic presentations of amphotericin B.
  • Effects of clotrimazole troches on tacrolimus dosing in heart transplant recipients. [Journal Article]
    Transpl Infect Dis 2018; 20(6):e12979Laub MR, Crow SA, … Razonable R
  • CONCLUSIONS: In conclusion, clotrimazole troches exert a meaningful interaction with tacrolimus that requires close monitoring and dose adjustment. The data from this single-center study provide novel information that could guide providers on the degree of tacrolimus dose adjustment needed when discontinuing clotrimazole prophylaxis after heart transplantation.
New Search Next